| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
G protein-coupled receptor kinase 2 | 0.532 | 0.654 | 1.00 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphodiesterase 5A | 0.513 | 0.731 | 1.1E-04 |
|
disease | 0.300 | None | 0.984 | 3 | 0 | 2002 | 2020 | ||||||||
|
melanoma cell adhesion molecule | 0.514 | 0.731 | 1.6E-04 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
histone deacetylase 3 | 0.511 | 0.731 | 0.57 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
cofilin 1 | 0.529 | 0.769 | 0.56 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2015 | 2015 | ||||||||
|
purinergic receptor P2Y1 | 0.551 | 0.769 | 0.52 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
protein kinase cGMP-dependent 1 | 0.603 | 0.769 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BCL2 associated agonist of cell death | 0.553 | 0.769 | 4.6E-03 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
dynein light chain LC8-type 1 | 0.568 | 0.769 | 0.70 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2005 | 2007 | ||||||||
|
insulin like growth factor binding protein 3 | 0.439 | 0.808 | 0.91 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2011 | 2014 | ||||||||
|
cannabinoid receptor 1 | 0.446 | 0.808 | 0.51 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
fatty acid binding protein 4 | 0.500 | 0.808 | 5.2E-05 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
purinergic receptor P2Y2 | 0.543 | 0.808 | 8.4E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
cyclin D2 | 0.477 | 0.808 | 0.99 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.520 | None | 1.000 | 1 | 0 | 1996 | 2017 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.260 | None | 1.000 | 3 | 0 | 2005 | 2018 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.600 | None | 1.000 | 3 | 0 | 1999 | 2019 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.510 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
endothelin receptor type A | 0.426 | 0.885 | 0.99 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2007 | 2008 | ||||||||
|
sirtuin 1 | 0.378 | 0.885 | 8.7E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
disease | 0.220 | None | 1.000 | 1 | 0 | 2006 | 2019 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
disease | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2002 |